Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single- or dual-mode fluorescence and PET imaging.

Cohen R, Vugts DJ, Stigter-van Walsum M, Visser GW, van Dongen GA.

Nat Protoc. 2013 May;8(5):1010-8. doi: 10.1038/nprot.2013.054. Epub 2013 Apr 25.

PMID:
23619892
2.

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.

Perk LR, Vosjan MJ, Visser GW, Budde M, Jurek P, Kiefer GE, van Dongen GA.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):250-9. doi: 10.1007/s00259-009-1263-1. Epub 2009 Sep 18.

3.

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA.

J Nucl Med. 2003 Aug;44(8):1271-81.

4.

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA.

J Nucl Med. 2003 Oct;44(10):1663-70.

5.

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.

Vosjan MJ, Perk LR, Visser GW, Budde M, Jurek P, Kiefer GE, van Dongen GA.

Nat Protoc. 2010 Apr;5(4):739-43. doi: 10.1038/nprot.2010.13. Epub 2010 Mar 25.

PMID:
20360768
6.
7.

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.

Muselaers CH, Stillebroer AB, Rijpkema M, Franssen GM, Oosterwijk E, Mulders PF, Oyen WJ, Boerman OC.

J Nucl Med. 2014 Jun;55(6):1035-40. doi: 10.2967/jnumed.114.137356. Epub 2014 Apr 21.

8.

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Lütje S, Rijpkema M, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC.

J Nucl Med. 2014 Jun;55(6):995-1001. doi: 10.2967/jnumed.114.138180. Epub 2014 Apr 3.

9.

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

Perk LR, Visser OJ, Stigter-van Walsum M, Vosjan MJ, Visser GW, Zijlstra JM, Huijgens PC, van Dongen GA.

Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45. Epub 2006 Jul 11.

PMID:
16832633
10.

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.

ter Weele EJ, Terwisscha van Scheltinga AG, Kosterink JG, Pot L, Vedelaar SR, Lamberts LE, Williams SP, Lub-de Hooge MN, de Vries EG.

Oncotarget. 2015 Dec 8;6(39):42081-90. doi: 10.18632/oncotarget.5877.

11.

Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.

Meijs WE, Haisma HJ, Klok RP, van Gog FB, Kievit E, Pinedo HM, Herscheid JD.

J Nucl Med. 1997 Jan;38(1):112-8.

12.

Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT.

Walther M, Gebhardt P, Grosse-Gehling P, Würbach L, Irmler I, Preusche S, Khalid M, Opfermann T, Kamradt T, Steinbach J, Saluz HP.

Appl Radiat Isot. 2011 Jun;69(6):852-7. doi: 10.1016/j.apradiso.2011.02.040. Epub 2011 Mar 2.

PMID:
21397511
13.

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.

Bhattacharyya S, Kurdziel K, Wei L, Riffle L, Kaur G, Hill GC, Jacobs PM, Tatum JL, Doroshow JH, Kalen JD.

Nucl Med Biol. 2013 May;40(4):451-7. doi: 10.1016/j.nucmedbio.2013.01.007. Epub 2013 Feb 27.

14.

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2133-40.

15.

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA.

Cancer Biother Radiopharm. 2003 Aug;18(4):655-61.

PMID:
14503961
16.

Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.

Natarajan A, Habte F, Gambhir SS.

Bioconjug Chem. 2012 Jun 20;23(6):1221-9. doi: 10.1021/bc300039r. Epub 2012 Jun 11.

17.

Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets.

Cohen R, Stammes MA, de Roos IH, Stigter-van Walsum M, Visser GW, van Dongen GA.

EJNMMI Res. 2011 Dec 1;1(1):31. doi: 10.1186/2191-219X-1-31.

18.

Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.

Hong H, Severin GW, Yang Y, Engle JW, Zhang Y, Barnhart TE, Liu G, Leigh BR, Nickles RJ, Cai W.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):138-48. doi: 10.1007/s00259-011-1930-x. Epub 2011 Sep 10.

19.

Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies.

Rousseau J, Zhang Z, Dias GM, Zhang C, Colpo N, Bénard F, Lin KS.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):708-712. doi: 10.1016/j.bmcl.2017.01.052. Epub 2017 Jan 18.

PMID:
28131709
20.

89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals.

Vugts DJ, Visser GW, van Dongen GA.

Curr Top Med Chem. 2013;13(4):446-57. Review.

PMID:
23432007

Supplemental Content

Support Center